Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 Source Cluster: JCN Newswire Source Node: 1962795Time Stamp: Apr 10, 2024
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Source Cluster: JCN Newswire Source Node: 1953594Time Stamp: Mar 4, 2024
Chain-mapping methods for relativistic light-matter interactions Source Cluster: Quantum Journal Source Node: 1942803Time Stamp: Jan 30, 2024
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050 Source Cluster: JCN Newswire Source Node: 1935133Time Stamp: Jan 9, 2024
How Ubisoft, Xbox, and Blizzard Are Using AI to Make Next-Generation Games – Decrypt Source Cluster: Decrypt Source Node: 1915314Time Stamp: Nov 19, 2023
World Blockchain Summit Set the Stage for a Decentralized Future with Ground-breaking Insights and Collaborations Source Cluster: ACN Newswire Source Node: 1817237Time Stamp: Mar 22, 2023